Collaboration Between Interleukin Genetics And Geisinger
Sep 30th 2008Drug InformationObesity / Weight Loss / Fitness
Interleukin Genetics, Inc. (AMEX:ILI), and Geisinger Health System, have announced a research collaboration to explore the role of genetics in obesity. The goal of the collaboration is to develop a series of genetic tests that will help physicians better understand an individual’s inherited resistance to weight loss and, more specifically, gauge a patient’s likelihood of success with diet and other weight loss techniques.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
